Sign In

Ruby Tudor

CEO and Founder of MDisrupt

Ruby Gadelrab is a highly experienced commercial health executive with over 20 years of expertise in biotech, healthcare, and healthtech industries.

She is the CEO and Co-founder of MDisrupt, the world's first medical diligence company, and also heads Ruby Consulting Group, assisting companies in genetics, healthcare, and healthtech sectors with commercialization strategies.

Ruby's domain expertise includes health technologies, population health, precision medicine, DTC consumer genomics, clinical genomics, and cancer research.

Her commercial skills focus on developing and executing go-to-market strategies, channel and partnership strategies, B2B and B2C customer acquisition, brand creation, storytelling, design and implementation of global campaigns, KOL and influencer development.

She has a strong background in successfully developing B2B and B2C commercial strategies with a proven track record in high-impact marketing, branding, and commercialization initiatives.

Ruby Gadelrab has extensive international market experience in China, Latin America, EMEA, and APAC regions.

She excels in leadership by building, training, and motivating high-impact commercial teams globally.

In her educational background, Ruby studied Executive Program in Exponential Technologies at Singularity University and holds a BSc Hons in Molecular Biology from UCL.

Throughout her career, Ruby has held various key positions in renowned organizations such as Vice President Commercial Marketing at 23andMe, Senior Director Marketing at Affymetrix, and Founder & CEO at Ruby Consulting Group.

She has also been involved as a board member, advisor, mentor, and consultant in prominent healthcare and genomics companies including Genome Medical, Color Genomics, and Drawbridge Health.

Ruby Tudor
Add to my network

Location

Austin, Texas Metropolitan Area